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ABSTRACT 
 
The studies included in this thesis were designed to increase knowledge of the dual 
role of Actinobacillus actinomycetemcomitans, recognized as a periodontal pathogen but also as 
a member of normal oral flora. A. actinomycetemcomitans was selected to be the model species 
for periodontal pathogens based on various virulence factors providing it with pathogenicity and 
on its genetic heterogeneity, which resembles normal oral flora bacteria. The main hypothesis in 
the studies was that the pathogenic potential of A. actinomycetemcomitans strains differs among 
its evolutionary lineages, each including distinct serotypes. Certain clonal types of A. 
actinomycetemcomitans detected specifically in periodontitis were also hypothesized to exert an 
enhanced capacity for inducing/promoting systemic pathologies, such as atherogenesis. The aims 
of this work were to determine whether certain clonotypes of A. actinomycetemcomitans display 
an ecological advantage in subgingival flora and whether the competence for natural 
transformation, and thus, the contribution to clonal diversity, differs between A. 
actinomycetemcomitans strains. We also studied the composition of serotype-specific antigen 
and investigated in vitro whether differences are present in the proatherogenic potential between 
lipopolysaccharide (LPS) preparations of A. actinomycetemcomitans clonotypes.  
The clonal types of A. actinomycetemcomitans strains recovered from a group of 
consecutive bacterium-positive adult patients with chronic periodontitis were characterized using 
serotyping by immunodiffusion and genotyping by arbitrarily primed polymerase chain reaction 
(AP-PCR). The natural competence for transformation was detected by adding donor DNA 
which contained a spectinomycin resistance gene to the recipient A. actinomycetemcomitans 
cells and by cultivating the cells on a selective medium. The serotype-specific antigen of A. 
actinomycetemcomitans was isolated by affinity chromatography, characterized by silver 
staining, Western blots and displacement-ELISA, and used in rabbit immunization. A. 
actinomycetemcomitans LPS –induced proatherogenic changes in  murine macrophages (RAW 
264.7) were studied in the presence and absence of low density lipoprotein (LDL) as follows: 
LDL accumulation into the cells was detected by radioactively labelled  LDL and cytokine (IL-
1β and TNF-α) production by using commercial ELISA kits. The mRNA expression of high 
density lipoprotein (HDL) receptors on the macrophage surface was analyzed by real-time PCR.  
 The results indicated that A. actinomycetemcomitans serotype b could be cultured 
in elevated proportions of subgingival flora in inflamed periodontitis significantly more 
frequently than the other serotypes. The natural competence for transformation among A. 
actinomycetemcomitans was not related to the periodontal status of donor patients but showed 
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serotype dependence, matching the major branches of the genetic lineages, with strains of 
serotypes a, d, and e being transformable and strains of serotypes b and c being non-
transformable. Only one serotype d isolate was detected among the 120 isolates studied. To 
make an attempt to explain the rareness, the serotype d antigen was purified and used for 
immunization, revealing that the antigen contained LPS O-antigen and was immunogenic. 
Experiments conducted to compare the biological effects of LPS between serotypes b (JP2 and 
Y4) and d (IDH781) showed that JP2-LPS not only induced macrophage-derived foam cell 
formation but also decreased the adenosine triphosphate binding cascade (ABCA) 1 mRNA 
expression significantly more efficiently than LPS-IDH781. Y4 was not as effective inducer of 
these events as JP2.  Serotype b LPS induced TNF-α production by macrophages significantly 
more than IDH 781 LPS, whereas no differences were observed between the LPSs isolated from 
A. actinomycetemcomitans serotypes b and d in the induction of IL-1β. 
  In conclusion, A. actinomycetemcomitans serotype b and certain clonotypes of this 
serotype may have the ability to break the health-compatible homeostasis of normal oral flora 
and grow in elevated proportions in the subgingival flora of patients with periodontitis. The 
increased growth potential may make these clones more pathogenic than other A. 
actinomycetemcomitans clones in periodontitis. The competence for natural transformation may 
be unrelated to periodontal status, but transformability follows the known evolutionary branches 
of A. actinomycetemcomitans. The clonal diversity of the species may have been affected by the 
natural transformability. However, it is not known whether the strains benefit from the 
transformability or whether the nontransformable strains have lost or hidden their ability for 
transformation. The serotype–specific antigen of serotype d contains O-antigen of LPS and is 
unlikely to contain other capsular polysaccharides. This antigen is capable of immunization and 
may thus have other biological functions as well. The ability to induce/promote systemic 
pathogenesis may differ between LPSs isolated from different clones of A. 
actinomycetemcomitans, and the clones with high proatherogenic potential seem to be the same 
as those associated with periodontitis.   
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REVIEW OF THE LITERATURE 
 
1. PERIODONTITIS 
 
1.1 General characteristics and classification 
 
Periodontitis is a chronic multibacterial infection in the tooth-supporting tissues 
which may lead to loss of teeth. It is the most common bacterial infection in humans (Office of 
Surgeon General 2000). The disease is most frequently seen in the middle-aged and elderly 
populations worldwide (Papapanou 1996) but is occasionally also found among younger 
individuals. The prevalence of periodontitis in the Finnish adult population is 64%, and the 
prevalence of severe periodontitis is 21% (Terveys 2000). This is consistent with the findings in 
most populations; the prevalence of periodontitis has been found to vary between 40% and 70% 
(Papapanou 1996, 1999, Albandar 2002, Sheiham & Netuveli 2002), and advanced adult 
periodontitis typically has not exceeded 15% (Papapanou 1999). The prevalence of early onset 
periodontitis is low in all populations studied (Papapanou 1999). Periodontitis has various forms 
previously classified as adult periodontitis, early onset periodontitis, rapidly progressing 
periodontitis, necrotizing ulcerative periodontitis, and refractory periodontitis (American 
Academy of Periodontology 1989, 1996). Early onset periodontitis is subgrouped further into 
localized and generalized forms of prepubertal and juvenile periodontitis. The age relation was 
removed from the classification when the disease was re-categorized in 1999 into aggressive and 
chronic periodontitis with localized and generalized subgroups, necrotizing periodontal diseases, 
and periodontitis as a manifestation of systemic diseases (American Academy of Periodontology 
1999).  
 
1.2 Oral biofilms 
 
                         Biofilms are populations of microorganisms that are concentrated at interfaces 
and typically surrounded by an extracellular polymeric substance matrix (Costerton 1978). The 
ability to form biofilms is an ancient and integral characteristic of prokaryotes, and the visual 
characteristics of biofilms growing in diverse environments are strikingly similar (for review, see 
Hall-Stoodley et al. 2004). Normal bacterial flora grows as biofilm structures in many parts of 
the human body, including tooth surfaces. Normal flora refers to the bacteria invariably present 
in dominant numbers in healthy individuals (for review, see Asikainen & Chen 1999). A 
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bacterium of the normal flora can act as a pathogen if it is transferred from its natural habitat to 
sterile body parts. This is seen, for example, in patients with prosthetic valves, whose 
endocarditis has been caused by bacteria originating from the oral cavity. Staphylococcus 
epidermidis, which belongs to the normal flora of the skin, may also act as a pathogen if 
transferred to the circulation via canyls.  
                         Oral bacteria form biofilms on different oral surfaces, including hard enamel and 
cementum as well as epithelial cells (for review, see Kolenbrander 2000). The bacterial 
composition of the biofilm is unique from one oral site to another. Biofilms on the hard surfaces 
are usually several cell layers thick, whereas bacterial colonization of the mucosal surfaces often 
occurs as a monolayer (Kolenbrander 2000). The predominating organisms isolated from the 
teeth and gingival crevices of periodontally healthy individuals mainly include Gram-positive, 
facultatively anaerobic bacteria, and rarely black-pigmented Gram-negative anaerobic rods 
(Marcotte & Lavoie 1998). The microorganisms isolated from healthy mucosal surfaces include 
streptococci in the cheeks, palate, gingiva, and floor of the mouth, and streptococci, Veillonella 
spp., Peptostreptococcus spp., and Gram-positive and Gram-negative anaerobic rods, such as 
Prevotella spp., on the tongue (Marcotte & Lavoie 1998).  
                         More than 500 taxa have been cultured from periodontal pockets (Moore & 
Moore 1994).  Oral diseases seem to appear after an imbalance of normal oral flora, leading to 
the emergence of potentially pathogenic bacteria (Marcotte & Lavoie 1998). When periodontitis 
develops and progresses, the bacterial composition of the subgingival biofilm changes from the 
dominance of facultatively anaerobic Gram-positive bacteria to an anaerobic Gram-negative 
majority. The number and proportion of subgingival bacteria of certain species increase with 
progression of periodontitis.  
                         Over 400 bacterial phylotypes have been identified in patients with periodontitis 
by isolating the 16S rDNA from subgingival plaque samples and cloning the PCR-amplified 
DNA to Escherdia coli (Paster et al. 2001). The sequences of cloned 16S rDNA were used to 
determine species identity or closest relatives. The bacteria most commonly related to 
periodontitis include Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, 
Prevotella intermedia, Prevotella nigrescens, Micromonas micros (previously 
Peptostreptococcus micros), Tannerella forsythensis (previously Bacteroides forsythus), 
Campylobacter rectus, and Treponema denticola (Haffajee & Socransky 1994). Pathogens in 
periodontitis do not meet Koch’s postulates because of the multibacterial etiology and chronic 
nature of this infection. The possibility of a single microorganism causing natural periodontitis in 
humans is probably nonexistent, and the initiation and progression of periodontitis is a process 
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that lasts from months to years. However, A. actinomycetemcomitans, P. gingivalis, and T. 
forsythensis are oral bacteria that best meet the Socransky modification of Koch’s postulates 
(Socransky 1979, Socransky & Haffajee 1992) which states that the organism suspected of being 
a periodontal pathogen occurs in higher numbers in diseased subjects than in either nondiseased 
subjects or sites showing improvement after treatment, it possesses virulence factors relevant to 
the disease process, and it elicits a specific immune response. Results obtained from animal 
models support the pathogenicity of these three species. A. actinomycetemcomitans, P. 
gingivalis, and T. forsythensis were described in 1996 as specific periodontal pathogens and 
causative agents in periodontal disease. A recent review article of the literature from 1996 
onward supports also the importance of these pathogens in the initiation and/or progression of 
periodontitis (Ezzo & Cuttler 2004). 
                       P. gingivalis is strongly associated with periodontitis and is rarely detected among 
healthy individuals (for review, see Haffajee & Socrandky 1994). T. forsythensis is associated 
with refractory periodontitis (Haffajee & Socransky 1994). A. actinomycetemcomitans was 
selected to be the model organism in this work because of its intriguing role in the periodontal 
health and disease. On the one hand, it is strongly associated with periodontitis as a pathogen 
possessing a wide variation of virulence characteristics (Fives-Taylor et al. 1999). On the other 
hand, it is a genetically heterogenic species that is regarded as part of the normal oral flora.     
 
1.3. Actinobacillus actinomycetemcomitans in periodontitis 
  
 
A B
Figure 1. Typical smooth colony morphology of a laboratory A. actinomycetemcomitans strain (A), 
and rough colony morphology of a fresh clinical A. actinomycetemcomitans strain (B).  
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                       A. actinomycetemcomitans is a Gram-negative, non-motile, facultatively anaerobic 
coccobacillus that was first described by Klinger in 1912 as Bacterium actinomycetem comitans. 
A. actinomycetemcomitans belongs to the family Pasteurellaceae and is closely related to certain 
Haemophilus species, such as H. aphrophilus and H. paraphrophilus (Dewhirst et al. 1992). A. 
actinomycetemcomitans grows well at 37˚C in 5% CO2 in air, and fresh clinical isolates have 
typical rough colony morphology with an inner star-shaped figure and adhere tightly to the agar 
(Figure 1B). Cells of fresh rough-colony isolates have fimbriae (Scannapieco et al. 1987), which 
are needed for the adherence and colonization of the microorganism to the oral cavity (Fine et al. 
1999, Schreiner et al. 2003). When A. actinomycetemcomitans strains are subcultured in the 
laboratory, the colony morphology may spontaneously change from a rough to a smooth, 
nonadherent colony type, which fails to produce fimbriae (Figure 1A) (Inouye et al. 1990).   
 Colonization of the oral cavity by A. actinomycetemcomitans probably happens at 
an early age (Alaluusua & Asikainen 1988), but the bacterium can also be transmitted between 
adults whose oral flora is already established (Saarela et al. 1993). A. actinomycetemcomitans 
occurs at isolated periodontal pockets of the oral cavity (Christersson et al. 1992, Ebersole et al. 
1994). A. actinomycetemcomitans is associated with aggressive forms of periodontitis, especially 
with localized aggressive periodontitis (LAP, previously known as localized juvenile 
periodontitis, LJP) (Slots et al. 1980), but the bacterium can also be found in the oral cavity of 
healthy individuals (Table 1) (Zambon et al. 1985, Asikainen et al. 1986, Li et al. 2004, Yang et 
al. 2005).  
The oral cavity is the natural habitat of A. actinomycetemcomitans. The main 
reservoir of the bacterium is dental plaque and the subgingival area (Slots et al. 1980, Asikainen 
& Chen 1999). The detection rate of A. actinomycetemcomitans in total flora of samples varies 
between different studies depending on the detection method used, the periodontal status of 
subjects, and the geographical origin of the study population. In addition to periodontitis, A. 
actinomycetemcomitans has been isolated from several nonoral infections such as endocarditis, 
pericarditis, pneumonia, and abscesses (for review, see van Winkelhoff & Slots 1999). The 
origin of A. actinomycetemcomitans in these nonoral infections has been suggested to be the oral 
cavity of the patient, since the strains isolated from the oral cavity and nonoral sites have been of 
the same clonotype (Martin et al. 1998). 
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Table 1. Prevalence of A. actinomycetemcomitans in periodontitis and periodontal health. 
Periodontal statusa Prevalence (% of subjects) of 
A. actinomycetemcomitansb
Reference 
Healthy 10-30  Slots et al. 1980, 
Alaluusua & Asikainen 1988,  
Asikainen & Alaluusua 1993 
Early onset periodontitis 90  Slots et al. 1980,  
Zambon 1985, 
Asikainen 1986,  
Asikainen & Alaluusua 1993 
Adult periodontitis 30-50 Slots et al. 1980, 1986, 
Rodenburg et al. 1990, 
Asikainen & Alaluusua 1993, 
Nieminen et al. 1996 
a Classification of periodontitis based on American Association of Periodontitis 1989 
b A. actinomycetemcomitans detected by cultivation 
 
 
 
 
2. EVOLUTIONARY LINEAGES OF ACTINOBACILLUS 
ACTINOMYCETEMCOMITANS 
 
2.1 Population structure  
  
Strong evidence of an association between certain clones of A. 
actinomycetemcomitans   and periodontitis (Zambon et al. 1985, Asikainen et al. 1991, DiRienzo 
et al. 1994, Haubek et al. 1997, Bueno et al. 1998) as well as nonoral infections (Paju et al. 2000) 
has raised the question of whether some clones of the species are more virulent than the others, 
and whether these potentially high-virulence clones harbor genetic material different from that of 
the other clones of A. actinomycetemcomitans.  
The population structure of A. actinomycetemcomitans has been studied by 
multilocus enzyme electrophoresis (MEE) (Caugant et al. 1990, Poulsen et al. 1994), restriction 
fragment length polymorphism (RFLP) (Hayashida et al. 2000), and combinations of several 
methods (Kaplan et al. 2002). The electrophoretic types recovered by MEE are A. 
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actinomycetemcomitans -specific, and are distinguishable from the closely related Haemophilus 
species (Caugant et al. 1990). These A. actinomycetemcomitans MEE types have also shown a 
strong correlation with the serotype characteristic of the species (Poulsen et al. 1994). 
Phylogenetic and insertion sequence (Iss) analyses of A. actinomycetemcomitans strains have 
revealed similar results (Hayashida et al. 2000, Kaplan et al. 2002). The phylogenetic trees 
recovered by population structure analyses have been suggested to display the evolutionary 
lineages of A. actinomycetemcomitans with clear serotype distinction (Kaplan 2002) (Figure 2).  
The population structure of bacteria depends on the relative rates of two processes: 
first, divergence of evolutionary lineages through the accumulation of mutations, and second, 
transfer of genes between lineages (Hayashida et al. 2000). Various types of mobile genetic 
elements, such as bacteriophages, plasmids, and transposons, may move across evolutionary 
lineages of the bacteria and affect the phenotype and genotype of otherwise genetically identical 
strains. MEE can distinguish A. actinomycetemcomitans serotypes, but also smaller subgroups 
such as strains that have a deletion in the leukotoxin gene promoter region  (Brogan et al. 1994), 
and are known as JP2-like strains named after the strain JP2, from which the deletion was first 
detected. These clones constitute a single clone of serotype b, which is homogeneous by MEE 
typing as well as by some genomic restriction enzyme analysis (Haubek et al. 1996). The A. 
actinomycetemcomitans clones, whose MEE types differ from other clones of the same serotype, 
have been suggested to have accumulated mutations in their genome (Hayashida et al. 2000). 
More generally, the same authors suggest that the population structure of A. 
actinomycetemcomitans is based on the divergence of evolutionary lineages through the 
accumulation of mutations (Hayashida et al. 2000). Based on the clonal population structure and 
information on the origin of A. actinomycetemcomitans isolates, periodontitis may represent two 
different disease types with distinct etiologies and epidemiologies: one in which a wide variety 
of sero- and genotypes of A. actinomycetemcomitans may act as opportunistic pathogens, and 
another, more rapidly progressing type of disease associated with particular clonal types with 
elevated virulence potential (Hayashida et al. 2000). Some of the A. actinomycetemcomitans 
clones have been speculated to grow as elevated proportions in the oral subgingival flora 
(Asikainen & Chen 1999). Nevertheless, limited information exists on the relation between 
certain clones of A. actinomycetemcomitans and proportions of these clones of the total 
subgingival flora in periodontitis.    
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Figure 2. Phylogenetic tree showing evolutionary lineages of A. actinomycetemcomitans serotypes. Serotypes
b and c form distinct, monophyletic groups, whereas serotypes a, d, e, and f together form another group.
Within serotypes a, d, e, and f, serotypes a and d are evolutionally closer to each other than serotypes e and f,
and serotypes e and f are closer to each other than serotypes a and d. Horizontal branch lengths are not to scale
and do not metrically represent evolutionary change (modified from Kaplan et al. 2002).  
 
 
 
 
 
 
 
2.2. Natural transformation 
 
Natural transformation is a genetically regulated process in which a bacterium 
takes up extracellular DNA and incorporates it into its own genome by homologous 
recombination (Lorenz et al. 1994, Dubnau 1999). The purpose of natural transformation is not 
fully understood, but it has been proposed that the DNA can, for example, be used as a nutrient 
(Finkel et al. 2001) and in the DNA repair process (Michod et al. 1988). The phenomenon may 
also have an impact on the evolution of the bacterium due to genetic recombination. Natural 
transformation has been characterized in various bacterial species, and three different 
transformation systems have been identified: i) Gram-positive streptococcus bacillus (for review 
see Lunsford 1998), ii) Gram-negative Haemophilus-Neisseria, and iii) Helicobacter pylori 
systems (Lorenz et al. 1994, Dubnau 1999).  
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Some A. actinomycetemcomitans strains are known to be competent in natural 
transformation (Tøonjum et al. 1990, Sato et al. 1992, Wang et al. 2002). The characteristics of 
the natural competence of A. actinomycetemcomitans resemble those of Haemophilus influenzae, 
including the ability of A. actinomycetemcomitans cells to take up DNA fragments containing 9 
–bp uptake signal sequences of H. influenzae (Wang et al. 2002). The transformation frequencies 
of A. actinomycetemcomitans are 10-3 transformants per total colony-forming units (CFUs) 
(Wang et al. 2002), which resemble those of H. influenzae (Wang et al. 2002) and Actinobacillus 
pleuropneumoniae (Bossé et al. 2004), the latter also being a member of the family 
Pasteurellaceae. A. actinomycetemcomitans develops competence within 2 h after the cells have 
been plated onto fresh agar, but the growth phase of competent strains has not been examined 
(Wang et al. 2002). Competent A. pleuropneumoniae strains do not show growth phase 
differences in competence (Bossé et al. 2004); however the transformation frequency of H. 
influenzae increases as the cells progress from the early log phase to the late log phase (Redfield 
1991). The transformation frequency of H. influenzae can be further increased by transferring the 
culture into a nutrient-dependent medium (Herriot et al. 1970). The number of A. 
actinomycetemcomitans isolates screened for transformation has been relatively low (5 and 17 in 
the studies of Tøonjum and Wang, respectively), and thus, further screening is needed to clarify 
the evolutionary background of natural competence (Tøonjum et al. 1990, Wang et al. 2002).  
Examinations of different competence systems among diverse bacteria have 
identified a number of homologous proteins required for the binding, uptake, and transport of 
DNA.  These proteins are involved in type IV pilus expression, type II protein secretion 
pathway, twitching motility, and natural competence. Type IV pilus gene homologies pilABCD 
are also required for natural transformation of A. actinomycetemcomitans (Wang et al. 2003). 
The PilABCD of A. actinomycetemcomitans belongs to the type IV pilus biogenesis system, and 
the pilA, pilB, pilC, and pilD knockout mutants of transformable A. actinomycetemcomitans 
strains are nontransformable (Wang et al. 2003).  
 
2.3 Intraspecies diversity 
 
 A. actinomycetemcomitans is genetically heterogeneous. The species can be 
divided into subgroups based on several methods distinguishing between different phenotypic 
and genotypic features. Typing methods based on phenotype include serotyping by specific 
antibodies (Zambon et al. 1983, Saarela et al. 1992) and biotyping by carbohydrate fermentation 
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(Slots et al. 1980). Genotyping can be performed by restriction endonuclease analysis  (DiRienzo 
et al. 1994, van Steenbergen et al. 1994, Saarela et al. 1993, 1999, Kaplan et al. 2001), 
ribotyping (Saarela et al. 1993), arbitrarily primed PCR (AP-PCR) (Slots et al. 1993, Asikainen 
et al. 1995, Saarela et al. 1995, Dogan et al. 1999), and 16S rRNA sequencing (for review, see 
Tanner et al. 1994). Both phenotyping and genotyping have been useful in investigation of 
intraspecies diversity in A. actinomycetemcomitans. With these methods the species has been 
divided into several subgroups, each subgroup sharing similar characteristics such as pathogenic 
potential (Kaplan et al. 2002). Serotyping and biotyping have the lowest discriminating potential 
of the typing methods, whereas ribotyping and 16S rRNA sequencing have discriminated higher 
number of different clonotypes of A. actinomycetemcomitans  (van Steenbergen et al. 1994). The 
number of AP-PCR genotypes depends on the primers used. The number of genotypes has 
ranged between 9 and 20, when OPA randomized primers were used alone or in combination 
with each other (Slots et al. 1993, Asikainen et al. 1995, He et al. 1998, Dogan et al. 1999). A 
relationship exists between a given AP-PCR genotype and a polymorphism in the 16S rRNA. 
The AP-PCR genotype and 16S rRNA type are almost always of a certain serotype of A. 
actinomycetemcomitans (Asikainen et al. 1995, Kaplan et al. 2002). Serotype and genotype 
distributions of A. actinomycetemcomitans have been found to be related to periodontal status 
(Zambon et al. 1985, Asikainen et al. 1991, 1995, Paju et al. 2000). Moreover an association 
between some A. actinomycetemcomitans restriction length polymorphisms and periodontitis has 
been reported (DiRienzo et al. 1994, Bueno et al. 1998). 
Despite the genetic heterogeneity of A. actinomycetemcomitans species in 
Caucasian populations (Saarela et al. 1999), a single serotype and genotype of the organism 
usually (67-80%) colonize the oral cavity of an individual (Asikainen & Chen 1999), and this 
clone tends to persist in the oral cavity for years (Ehmke et al. 1999, Saarela et al. 1999). 
Controversial results have been observed in populations of other geographical origin. In a 
Japanese population, a single A. actinomycetemcomitans serotype per subject has been detected 
in 52% (Yoshida et al. 2003) and 95% (Yamamoto et al. 1997) of individuals, depending on the 
serotyping method used.  In Taiwanese (Yang et al. 2005) and Chinese (Mombelli et al. 1999) 
populations 80% and 85% of subjects, respectively, harbored one serotype of the organism.  
 Approximately 3% to 9% of A. actinomycetemcomitans strains remain repeatedly 
nonserotypeable by serological methods using polyclonal antisera (Saarela et al. 1992, Poulsen et 
al. 1994, Asikainen et al. 1995). Serologically nontypeable strains have been analyzed by various 
techniques, and they are distributed in all evolutionary lineages of the species (Poulsen et al. 
1994). This has led to the suggestion that these nonserotypeable strains originate from 
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serotypeable strains, most often from strains representing serotype c (Paju et al. 1998). A DNA-
based method using PCR amplification of serotype-specific sequences detects A. 
actinomycetemcomitans serotypes more sensitively than serotyping by serological methods 
(Suzuki et al. 2001). The nontypeable strains can be serotyped by PCR (Kanasi et al. 2003), 
which further supports the suggestion that strains nonserotypeable by serological methods have 
lost or hidden their serotype-specific antigenic determinants.   
 
2.4 Serotypes and serotype-specific antigens 
  
A. actinomycetemcomitans is divided into six serotypes, from a to f (Zambon et al. 
1983, Saarela et al. 1992, Kaplan et al. 2001). In most studies on A. actinomycetemcomitans 
serotypes, the bacterium has been serotyped by immunodiffusion or immunofluorescence assays 
using polyclonal or monoclonal antibodies against serotype-specific cell surface antigens. Quite 
recently, Koga and coworkers published a PCR-based method to group A. 
actinomycetemcomitans strains into serotypes (Suzuki et al. 2001).  The serotype-specific 
antigens of A. actinomycetemcomitans have been studied extensively, and the results suggest that 
the antigen is a cell surface polysaccharide of A. actinomycetemcomitans (Amano et al. 1989, 
Page et al. 1991, Wilson & Schifferle 1991, Perry et al. 1996a, 1996b).  Both the genetic locus 
that encodes the serotype-specific antigens of each serotype and the sugar composition (Table 2) 
of the serotype-specific antigens are known (Perry et al. 1996a, 1996b, Nakano et al. 1998, 
Yoshida et al. 1998, 1999, Nakano et al. 2000a, Kaplan et al. 2001, Suzuki et al. 2001).  
Consensus exists that the serotype-specific antigen is a polysaccharide, but there 
are controversial results regarding whether this polysaccharide antigen resides in the O-antigen 
of a lipopolysaccharide (LPS) (Page et al. 1991, Wilson & Schifferle 1991), or on the surface of 
a bacterium distinct from LPS (Amano et al. 1989, Califano et al. 1989). An O-antigen is a 
structure showing variation in the LPS, whereas the lipid A portion is highly conserved (Figure 
3). Lipid A of A. actinomycetemcomitans contains two major fatty acids, namely myristic acid 
and β-OH myristic acid with glucosamine (Kiley & Halt 1980, Masoud et al. 1991). Studies 
describing the location of the serotype-specific antigen have mainly focused on serotype b strains 
of A. actinomycetemcomitans (Amano et al. 1989, Page et al. 1991, Wilson & Schifferle 1991, 
Perry et al. 1996a). Serotype-specific antigens of serotypes d and e have been studied least, and 
only the sugar composition of the O-antigen of LPS and the genetic locus encoding the antigen 
are known (Perry et al. 1996b, Yoshida et al. 1999, Nakano et al. 2000). There are no reports in 
the literature stating the exact location of serotype-specific antigens of serotypes d and e.  
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Figure 3. Schematic structure of LPS of A. actinomycetemcomitans. Phosphates and other substitutes have been
omitted from the structure. O-antigen of A. actinomycetemcomitans serotype d is composed of repeating tetrasaccharide
units, whereas the O-antigen of serotypes a, c, and e is composed of repeating disaccharide units and O-antigen of
serotypes b and f of repeating trisaccharide units (modified from Brade et al. 1988). 
 
 
 
Serotype-specific antigens for serotypes b, c, e, and f are a product of gene clusters 
containing 10-16 genes (Suzuki et al. 2001). All of the gene clusters contain highly conserved 
groups of genes at the proximal and distal ends, but the central genes are unique to each serotype 
and contain lower GC content (Figure 4) (Nakano et al. 1998, Yoshida et al. 1998, Kaplan et al. 
2001). Because of the low GC content, these serotype-specific gene clusters have has been 
purposed to evolve from a common ancestral cluster by gene transfer from a species with a low 
GC content (Nakano et al. 1998, Kaplan et al. 2001). Serotype a and d gene clusters are unrelated 
to the other four serotype-specific gene clusters (Shibuya et al. 1991, Nakano et al. 2000). 
Serotype d gene cluster is located 2 kb downstream from the b, c, e, and f clusters, whereas 
serotype a is encoded by a fragment of chromosomal DNA located away from the other 
serotype-specific sites (Suzuka et al. 2001).  
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Glycosyltransferases ABC  
transporter 
d-TDP-L-rhamnose
synthesis 
Figure 4. Comparison of serotype-specific gene clusters from A. actinomycetemcomitans serotypes b, c, and e.
Black arrows, open reading frames (ORFs) with greater than 90% identity among strains; gray arrows, ORFs
with 40% to 60% identity; open arrows, ORFs with no corresponding gene in the other strains. Lines demarcate
homologous regions (modified from Kaplan et al. 2001). 
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Table 2. Sugar composition of serotype-specific antigens of A. actinomycetemcomitans. 
Serotype Sugar composition Comments Reference 
 
a 
 
6-deoxy-D-talose 
 
Serotype a–specific antigen is composed of only one 
sugar. This disaccharide structure is unique among 
bacteria. 
 
 
Shibuya et al. 1991, 
Perry et al. 1996a,  
Mäki et al. 2003 
 
b D-fucose and L-
rhamnose 
 
D-fucose is found only in a few bacterial species. Its 
biosynthesis was first reported in A. 
actinomycetemcomitans. 
Amano et al. 1989, 
Perry et al. 1996b, 
Yoshida et al. 1999, 
Nakano et al. 2000b
 
c 6-deoxy-L-talose 
 
Serotype c–specific antigen is composed of only one 
sugar and has a unique disaccharide structure. 
 
Shibuya et al. 1990, 
Perry et al. 19996a 
 
d D-glucose, D-mannose 
and L-rhamnose 
 
Contrary to the other serotypes, serotype d–specific 
antigen has an α-linked L-rhamnose side branch 
attached to one of the two D-mannose residues. 
 
Perry et al. 1996a, 
Nakano et al. 2000a
e 2-acetamino-2deoxy-
D-glucose and L-
rhamnose 
 
Serotype e polysaccharide is an unbranched high-
molecular-mass polymer composed of repeating 
disaccharide units. 
Perry et al. 1996a, 
Yoshida et al. 1999 
f L-rhamnose and 2-
acetamiddo-2-deoxy-
D-galactose 
Serotype f polysaccharide contains a β-D-GalpNAc 
epitope in its polysaccharide backbone, similar to 
serotype b. 
Kaplan et al. 2001 
 
 
 
 
 
 
2.5 Serotypes vs. genotypes 
 
 A. actinomycetemcomitans genotypes, including AP-PCR and 16S rRNA  types, 
follow a serotype distribution (Asikainen et al. 1995, Kaplan et al. 2002, Kanasi et al. 2003). A 
given AP-PCR genotype is almost always of a set serotype (Asikainen et al. 1995, Dogan et al. 
1999), and the number of AP-PCR genotypes within each serotype ranges between 2 for serotype 
 22
d and 6 for serotype b (Asikainen et al. 1995, Dogan et al. 1999). Some AP-PCR genotypes have 
been related to the periodontal status of the origin or to certain virulence characters of the species 
(Asikainen et al. 1997). The genotype distribution in the Finnish population has been reported to 
be different between patients with LJP and those with adult periodontitis (Asikainen et al. 1997). 
 The number of 16S rRNA types is smaller than the number of A. 
actinomycetemcomitans serotypes, and different serotypes can belong to the same 16S rRNA 
type (Kaplan et al. 2002). Because of the similarities in the 16S rRNA types between different 
serotypes, the 16S rRNA types have been suggested to show the evolutionary branches of the 
species (Kaplan et al. 2002).       
 
 
3. ACTINOBACILLUS ACTINOMYCETEMCOMITANS AND SYSTEMIC HOST 
RESPONSES 
 
 
To establish an infection, the pathogen must overcome several levels of defense; 
numerous surface barriers, such as epithelium and mucus, the innate immunity, and adaptive 
immunity (Delves & Roitt 2000). In the oral cavity, the pathogen first comes into contact with 
epithelial cells of the mucosa, natural and artificial tooth surfaces, and other artificial solid 
surfaces, activating a wide range of inflammatory and immune responses (Kagnoff & Eckmann 
1997). In periodontitis, inflammation of the gingival tissue leads to microulcerations in the 
sulcular epithelium. Bacteria and bacterial components have access to the blood circulation 
during mechanical injury to inflamed gingival tissue (Silver et al. 1977).  
A. actinomycetemcomitans has several potential virulence factors, all of which have 
roles in the progression of periodontitis: i) adhesins, invasins, and bacteriocins promote 
colonization and persistence in the oral cavity; ii) toxins, such as endotoxin or LPS, leukotoxin, 
and cytolethal distending toxin, chemotactic inhibitors, immunosuppressive proteins, and Fc-
binding proteins interfere with the host’s defenses; iii) collagenases, bone resorption agents, and 
stimulators of inflammatory responses destroy host tissues; and iv) inhibitors of host tissue repair 
(for review, see Fives-Taylor et al. 1999, Tan et al. 2002). Some of these virulence factors are 
related to certain clonotype of the species (Table 3). It is possible that the same virulence factors, 
that are active in oral infectious diseases, also have a role in the initiation and progression of host 
reactions contributing to the systemic diseases.  
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 Table 3. Clonal variation in the virulence factors of A. actinomycetemcomitans 
Virulence factor Biological function Variation within 
clonotype 
Reference 
Lipopolysaccharide 
(LPS) 
High potential of 
destroying of an array of 
host cells and tissues 
 
O-antigenic part of LPS 
differs between serotypes, 
but differences in the 
biological functions are 
unknown  
 
Perry et al. 1996a, 1996b, 
Fives-Taylor et al. 1999 
Leukotoxin (lkt) Binds host immune cells 
and forms pores in the 
membranes of the target 
cells, causing cell death 
 
Serotype b is associated 
with high production of 
lkt 
Haubek et al. 1996,  
Barretto Tinoco et al. 
1997,  
Fives-Taylor et al. 1999 
Cytolethal distending 
toxin (cdt) 
Arrests cells in the G2 
phase of the cell cycle 
Serotype c is associated 
with decreased production 
of cdt  
Sato et al. 2002, 
Tan et al. 2002,  
Leung et al. 2005 
 
 
 
3.1. Periodontitis and cardiovascular diseases 
 
 Traditional risk factors for cardiovascular diseases (CVD), including high serum 
cholesterol, smoking, high blood pressure, and diabetes, explain only 50% of the CVD cases 
(Leaverton et al. 1987, Epstein et al. 1999). Increasing evidence suggests that chronic infections, 
such as dental infections, increase the risk for CVD (Mattila et al. 1989, Noll et al. 1998). 
Among dental infections, periodontitis in particular seems to increase the risk for CVD (Beck et 
al. 1998). The mechanisms underlying the association between periodontitis and CVD are only 
partly understood. The development of periodontitis is characterized by local inflammatory 
response via the monocyte/lymphocyte axis (Salvi et al. 1998). The formation of macrophage-
derived foam cells containing large amounts of cholesterol esters is a hallmark of early 
atherosclerosis (for review, see Glass & Witztum 2001). Cholesterol accumulation in these cells 
is thought to be mediated primarily by uptake of modified forms of low-density lipoprotein 
(LDL) via scavenger receptors (Yamada et al. 1998). Bacterial surface components, such as LPS, 
can modify LDL directly or by activating macrophages to produce superoxides. These 
modifications may vary from minimal modification to extensive oxidation, acetylation, or 
aggregation (Glass & Witztum 2001).  
 Contrary to single-pathogen infections due to e.g. C. pneumoniae and H. pylori, it 
is difficult to assess the relationship between periodontitis and CVD using a single pathogen. 
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However, accumulating evidence suggests that A. actinomycetemcomitans, among certain other 
periodontal species, may have a role in atherogenesis; 16S rDNA of A. actinomycetemcomitans 
has been detected from atherosclerotic plaques of endarterectomy specimens by PCR 
(Harazarthy et al. 2000). A recent study indicated that A. actinomycetemcomitans and P. 
gingivalis recovered from atheroma plaque were viable although noncultivable (Kozarov et al. 
2005). The viability was assessed by incubating carotid atherosclerotic plaque homogenates with 
endothelial cells, followed by detection of bacteria by immunofluorescence using monoclonal 
antibodies. However, the evidence for the viability was indirect and based on the assumption that 
bacteria need to be viable to invade nonphagocytic cells (Kozarov et al. 2005). The presence of 
bacteria were confirmed with real-time PCR, which was used to detect and quantify bacterial 
DNA from the lesion material. The amount of A. actinomycetemcomitans DNA in these 
atheroma plaque samples was three times as high as that of P. gingivalis DNA (Kozarov 2005).  
 
A recent series of seroepidemiological studies provides further evidence for the 
association between periodontitis infection and certain pathogens in CVD. Elevated levels of 
serum IgG antibodies to A. actinomycetemcomitans and P. gingivalis are associated with 
prevalent coronary heart disease (CHD) in men (Pussinen et al. 2003), and high serum antibody 
levels to A. actinomycetemcomitans have been shown to predict future risk of stroke and CHD 
(Pussinen et al. 2004a, 2005). Subjects healthy at baseline but whoexperienced a stroke during 
the 13-year follow-up were more often seropositive for A. actinomycetemcomitans than subjects 
free of stroke (Pussinen et al. 2004a). Finnish men without CVD at baseline but who experienced 
an acute myocardial infarction (AMI) or CHD death during the 10-year follow-up, had an 
increasing risk for CHD endpoint with increasing levels of serum IgA-class antibodies to A. 
actinomycetemcomitans (Pussinen et al. 2005). Both IgA and IgG antibody levels to A. 
actinomycetemcomitans also correlated positively with carotid intima-media thickness, 
suggesting a contribution of A. actinomycetemcomitans already to subclinical atherosclerosis 
(Pussinen et al. 2005). Although salivary IgG and IgA antibody levels against periodontal 
pathogens are higher in periodontitis patients than in periodontally healthy individuals 
(Nieminen et al. 1993, 1996, Kinane et al. 1999), the significance of  elevated serum IgA levels 
to these pathogens is less understood. Since serum and salivary IgA levels are known to correlate 
positively with each other (Nieminen et al. 1993, 1996), particularly aggressive forms of 
periodontitis that are often attributed to the involvement of A. actinomycetemcomitans may 
predict an elevated risk for CVD.  
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 A recent study on patients with periodontitis also addressed the significance of 
periodontal pathogens in CVD. A relationship was found between carotid intima-media 
thickness and subgingival periodontal microbiota as detected by checkerboard DNA-DNA 
hybridization (Desvarieux et al. 2005). Periodontopathogen burden correlated positively with the 
intima-media thickness, also after adjusting for C-reactive protein concentration and white blood 
cell counts. A. actinomycetemcomitans dominance was seen in the group of bacterial species 
etiologically important in periodontitis. 
 
Infection and inflammation play a role in the lipoprotein metabolism (for review, 
see Khovidhunkit et al. 2004). Recent studies show an association between periodontitis and an 
unfavorable lipid profile as characterized by high serum concentrations of total cholesterol, LDL 
cholesterol, and triglycerides (Lösche et al. 2000, Katz et al. 2002). Interesting information of the 
relationship between periodontal inflammation and cholesterol metabolism was reported from a 
group of patients with periodontitis before and after periodontal treatment (Pussinen et al. 
2004b). The number of periodontal pockets bleeding on probing at baseline correlated positively 
with the serum LPS concentration and the in vitro uptake of patient’s LDL by macrophages as 
well as with production of proinflammatory cytokines (IL-1b, TNF-α) by the same cells. Other 
researchers have also reported an association between the number of periodontal pockets and 
plasma LDL cholesterol concentrations (Katz et al. 2002). High-density lipoprotein (HDL) is 
considered an antiatherogenic lipoprotein since it protects LDL against oxidation (Mackness et 
al. 2000), has a role in reverse cholesterol transport (Fielding & Fielding 1995), and neutralizes 
LPS in the circulation (Levine et al. 1993). Periodontitis has been shown to be associated with 
low concentrations of HDL (Pussinen et al. 2004c), an independent risk factor for CHD 
(Assmann 1992). HDL isolated from A. actinomycetemcomitans–positive patients with 
periodontitis had a lower capacity to accept cholesterol from macrophages (cholesterol efflux) 
than HDL isolated from A. actinomycetemcomitans –negative patients. Moreover, the efflux 
capacity of A. actinomycetemcomitans–positive patients increased significantly after periodontal 
treatment. Thus, periodontitis may diminish the antiatherogenic potency of HDL . 
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3.2 Actinobacillus actinomycetemcomitans lipopolysaccharide as a stimulant of host 
responses related to cardiovascular diseases  
 
LPS is a major factor responsible for toxic manifestations of severe Gram negative infections 
(for review, see Rietschell et al. 1994), and it may also act as a proatherogenic agent. LPS 
isolated from E. coli (Funk et al. 1993), Chlamydia pneumoniae (Kalayoglu et al. 1998, 
Kalayoglu & Byrne 2000), and P. gingivalis (Qi et al. 2003) has been shown to induce 
macrophage-derived foam cell formation. Biological activities of LPS are determined by the 
shape and composition of their lipid A portion (Schromm et al. 2000). However, the O-antigen 
might also influence the biological activities of lipid A (Kondakova et al. 2004).  
  Human serum responses are specific for A. actinomycetemcomitans LPS (Ebersole et al. 
1983). Especially the levels of IgM antibodies against A. actinomycetemcomitans LPS are 
elevated in both juvenile and adult periodontitis (Ebersole et al. 1983). In the sera of localized 
juvenile periodontitis subjects, determinants of the O-antigen of A. actinomycetemcomitans LPS 
are the principal targets for opsonic IgG antibodies (Wilson & Bronson 1997). Affinity-purified 
IgG antibodies towards LPS of A. actinomycetemcomitans facilitate phagocytosis and killing by 
human neutrophils significantly more than anti-LPS-depleted antibodies (Wilson & Bronson 
1997). The variable antibiotic susceptibility of A. actinomycetemcomitans serotypes (Pajukanta 
et al. 1993) might be partially due to the differences in the O-antigen of different A. 
actinomycetemcomitans serotypes. The antibiotic susceptibility of nonserotypeable and 
serotypeable A. actinomycetemcomitans strains differ in the same individual (Paju et al. 2000), 
further supporting this hypothesis.  
 
Increased levels of serum proinflammatory cytokines are considered inflammatory markers 
of CVD, even though it is not yet known whether they have a causal relation to CVD or whether 
the association simply reflects an underlying disease process (for review, see Paoletti et al. 
2004). Changes in the acute-phase proteins, such as C-reactive protein (CRP), are mediated by 
proinflammatory cytokines produced in response to a variety of stimuli in multiple cell types, 
including macrophages (Gabay & Cushner 1999). Proinflammatory cytokines play a role in both 
the initiation and progression of atherogenic events (for review, see Libby 2002). They increase 
the expression of vascular cell adhesion molecule –1 (VCAM-1) on the surface of endothelial 
cells of the vessel wall through a nuclear factor-κB-mediated pathway (Collins & Cybulsky 
2001). Monocytes bind to the VCAM-1, migrate into the intima through the junctions between 
epithelial cells, and mature into macrophages (Libby 2002). Proinflammatory cytokines also 
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stimulate macrophages to become lipid-laden foam cells in the presence of excess cholesterol, 
and take part in the rupture of atheroma by increasing endothelial cell death, stimulating and 
activating matrix metalloproteinases specialized in degrading components of subendothelial 
basement membranes, and by inhibiting collagenase synthesis in fibrous caps (Libby 2002). 
They also interfere with lipoprotein metabolism, which can be first seen as increased triglyceride 
and decreased total cholesterol concentrations in serum during the acute phase of infection or 
inflammation (for review, see Khovidunkhit et al. 2004). 
Proinflammatory cytokines also play a pivotal role also in the initiation, regulation, and 
perpetuation of periodontitis (for review, see Taylor et al. 2004), and patients with severe 
periodontitis have increased serum cytokine levels (Imatani et al. 2001, Ohguchi et al. 2003). 
This can also be seen systematically, since serum LPS concentration of patients with 
periodontitis correlates positively with TNF-α production by macrophages (Pussinen et al. 
2004b), and periodontal treatment leads to a decrease in serum levels of inflammatory mediators 
CRP, serum amyloid A (SAA), fibrinogen, and IL-6  (D’Aiuto et al. 2004, Pussinen et al. 
2004c). Low LPS concentrations of A. actinomycetemcomitans stimulate human macrophages 
and markedly increase their expression levels of mRNA coding interleukin IL-1α, IL-1β, and 
TNF (Saglie et al. 1990). LPS isolated from A. actinomycetemcomitans induces the secretion of 
IL-1β, IL-6, and TNF-α in human whole blood (Schytte Blix et al. 1999), in human gingival 
fibroblasts in vitro (Imatani et al. 2001), in monocytes from patients with periodontitis in vitro 
(Nagasawa et al. 2004), and in mouse models in vivo (Kato et al. 2000).  
  
LPS also affects the expression of several receptors, e.g. scavenger receptors, on the cell 
surface of macrophages (Gordon 1999). The scavenger receptor superfamily is composed of 
members with diverse structures, expression patterns, and functions that are implicated in 
unrestrictive cholesteryl ester accumulation in macrophages, lipid droplet formation, and 
ultimately, atherosclerosis (Francone 2003). Scavenger receptor class B1 (SR-B1) is a 509-
amino acid -long member of the CD36 superfamily of proteins. It binds HDL with high affinity 
(Krieger & Kozarsky 1999) and facilitates the bidirectional efflux of free cholesterol between 
cells and HDL (Jian et al. 1998). Murine atherosclerosis models have shown the antiatherogenic 
effects of SR-B1 (for review, see Krieger 2001, Trigatti et al. 2004). SRs may also have diverse 
functions, e.g. in the regulation of inflammation by binding LPS and protecting the host from 
endotoxic shock as well as by assisting in the resolution of inflammation by increasing HDL 
levels in the circulation, which then bind and neutralize excess LPS (Peiser & Gordon 2001), and 
in transporting cholesterol to the macrophages, which then use it in the host defense during the 
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acute phase (Khovidhunkit et al. 2004). SRs also have a role in the apoptosis by recognizing the 
phosphatidyl serine on the cell surfaces of apoptotic cells (Boullier et al. 2001).  
The adenosine triphosphate (ATP) -binding cassette superfamily is another receptor family 
that takes part in HDL efflux. They are active transporters composed of about 50 functionally 
diverse prokaryotic and eukaryotic transmembrane proteins which are fundamental to membrane 
transport of a broad variety of substrates, including lipids and lipopolysaccharides (for review, 
see Štefková et al. 2004). ATP-binding cassette transporter A1 (ABCA1) is a 2261 amino acid 
integral membrane protein (Rust et al. 1999) that facilitates the efflux of cellular phospholipids 
and cholesterol to HDL proteins (Wang et al. 2001). The precise mechanism by which ABCA1 
acts is still unclear, but strong evidence suggests that ABCA1 is involved not only in the 
cholesterol efflux from peripheral tissues but also in influencing the production of HDL by the 
liver and the rate of cholesterol absorption by the gut (Knight 2004). 
LPS downregulates the expression levels of HDL receptors in macrophages (Van Lenten et 
al. 1985, Baranova et al. 2002, Khovidunkit et al. 2004). LPS isolated from E. coli and 
Salmonella enterica mutant LPS downregulated the expression of ABCA1 and SR-B1 mRNA as 
well as protein production of SR-B1 (Baranova et al. 2002). The monophosphoryl lipid A mutant 
was found to be a less potent modulator of SR-B1 and ABCA1 gene expression than complete or 
diphosphoryl lipid A mutant LPS, but the differences were detected only at low LPS 
concentrations. This finding suggests that the phosphorylated lipid A portion of LPS is required 
for maximal LPS effects on SR-B1 and ABCA1 receptors.  The downregulation of these 
receptors decreased also cholesterol efflux from mouse macrophages. Cytokines tumor necrosis 
factor (TNF) and interleukine 1 (IL-1) downregulate the levels of ABCA1 in murine 
macrophages, and mRNA and protein levels of ABCA1 are similarly inhibited (Khovidunkit et 
al. 2003).  
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AIMS OF THE STUDY 
 
The main hypothesis of studies I-IV was that the pathogenic potential of A. 
actinomycetemcomitans strains differs between the evolutionary lineages, and thus, between 
serotypes of the species. A. actinomycetemcomitans clones with particular pathogenic 
characteristics in periodontitis were also hypothesized to exert an enhanced capacity to 
induce/promote proatherogenic reactions. 
 
Specific aims were as follows: 
 
1. to determine whether certain clonotypes of A. actinomycetemcomitans show an ecological 
advantage in subgingival flora as determined by their elevated proportions in patients with 
chronic periodontitis (I). 
 
2. to investigate whether the competence for natural transformation, and thus, the contribution to 
clonal diversity, differs between A. actinomycetemcomitans strains representing different 
clonotypes and originating from different periodontal conditions (II). 
 
3. to clarify whether the serotype-specific antigen is located in the LPS of A. 
actinomycetemcomitans (III). 
 
4. to investigate in vitro whether differences are present between LPS preparations of selected A. 
actinomycetemcomitans clonotypes in inducing proatherogenic effects (IV).  
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MATERIALS AND METHODS 
 
Detailed descriptions of materials and methods are described in the original publications. 
 
1. SUBJECTS AND BACTERIAL STRAINS 
 
A total of 181 clinical and 10 control A. actinomycetemcomitans strains were isolated from 
an equal number of individuals in Studies I-IV (Table 4). Of these clinical strains, 159 were 
derived from Finland and 22 from USA. The pooled bacterial samples were collected with sterile 
curettes from the most inflamed and deepened periodontal pockets. The samples were 
transported to the laboratory within 24 h in vials containing 2 ml of VMGA III medium. The 
subjects had not received antibiotics in dental care for the last 6 months.    
Table 4. A. actinomycetemcomitans strains used in the study. 
 
Control strain  
 
Serotype 
 
Study 
 
ATCC 29523 
JP2 
Y4 
HK1651 
ATCC 29524 
ATCC 29522 
ATCC 43758 
ATCC 33384 
IDH 781 
IDH 1708 
 
a 
b 
b 
b 
b 
b 
b 
c 
d 
e 
 
I, II, III 
II, IV 
II, IV 
II 
II 
II 
I, III 
I, II, III 
I, II, III, IV 
I, II, III 
 
Clinical strains 
 
Periodontal status 
 
Study 
 
121 isolates from an equal number of consecutive A. 
actinomycetemcomitans–positive Caucasian patients 
with periodontitis 
 
Chronic periodontitis 
 
I 
 
38 A. actinomycetemcomitans isolates from 
Caucasian individuals selected on the basis of the 
serotype of the isolates for genetic variation 
 
17 aggressive periodontitis 
19 chronic periodontitis 
2 periodontally healthy 
 
II 
22 A. actinomycetemcomitans isolates from 16 
Hispanic individuals and 6 individuals of African 
origin selected on the basis of the serotype of the 
isolate.   
Chronic periodontitis  
II 
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 The clinical A. actinomycetemcomitans isolates were recovered from cultured subgingival 
plaque samples, identified by conventional means, and stored in skim milk at -70ºC. The first 60 
A. actinomycetemcomitans-positive subgingival samples in Study I were additionally cultured for 
the following periodontal pathogens: Porphyromonas gingivalis, Tannerella forsythensis, 
Prevotella intermedia/Prevotella nigrescens, Micromonas micros, and Campylobacter rectus. 
Identification of the bacterial species was carried out by established methods (Asikainen et al 
1986, Saarela et al. 1993, von Troil-Lindén et al. 1995, Mättö et al. 1996, Alaluusua et al. 1997). 
A. actinomycetemcomitans strains were grown on Brucella agar plates and incubated in 5% 
CO2 in air at 37ºC for 2-3 days. The purity of the strains was based on colony morphology and 
Gram staining.  
 
2. EUKARYOTIC CELLS AND CELL CULTURES 
 
Study IV, RAW 264.7 macrophages, a murine macrophage-like cell line, was obtained 
from the American Type Culture Collection (Rockville, MD, USA). The cells were cultivated at 
37°C in 5% CO2 in RPMI 1640 medium (Gibco, Invitrogen Corporation, UK) supplemented 
with 10% (v/v) fetal calf serum, 100 units/ml penicillin, and 100 µg/ml streptomycin. The cells 
were subcultured three times a week for 1-2 weeks.  
 
 
3. METHODS 
 
3.1 Serotyping (I, III) 
In Study I, A. actinomycetemcomitans strains were serotyped by the 
immunodiffusion method as described elsewhere (Saarela et al. 1992). The isolates were revived 
and subcultured on supplemented Brucella agar plates and checked for purity. Immunodiffusion 
was carried out on Noble agar plates using serotype-specific polyclonal antisera against A. 
actinomycetemcomitans control strains (ATCC 29523, ATCC 43758, ATCC 33384, IDH 781, 
IDH 1708) of the serotypes a-e. Autoclaved bacterial cell extracts were used as antigens. 
In Study II, the bacterial strains were serotyped by a PCR method as described 
previously (Kaplan et al. 2001, Suzuki et al. 2001). Briefly, genomic DNA was isolated from the 
cell cultures by using a commercial kit (DNAeasy, Qiagen). The multiplex PCR reaction 
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contained specific primers (Table 5) for A. actinomycetemcomitans serotypes a-e. Amplification 
products were analyzed in 1.5% agarose gel containing ethidium-bromide (0.5 µl/ml) and 
photographed under ultraviolet light. The serotype was determined according to the molecular 
mass of the amplification product. If the results from the PCR reaction for serotypes a-e were 
negative (no amplification products), the PCR reaction was repeated using primers for serotype f 
(Kaplan et al. 2001). 
 
3.2 Genotyping (I, II) 
For the genotyping by arbitrarily primed polymerase chain reaction (AP-PCR), 
chromosomal DNA of A. actinomycetemcomitans isolates was isolated as described earlier 
(Saarela et al. 1995). Briefly, pure cell cultures were lysed with lysozyme and proteinase K 
(Sigma Chemical Co., St. Louis, MO, USA), followed by phenol-chloroform extraction of the 
proteins and precipitation of the DNA by ethanol. The random primer used in the amplification 
procedure was OPA-13 (Table 5) (Dogan et al. 1999). The amplification products were analyzed 
electrophoretically in 1% agarose gel containing ethidium-bromide (0.5 µl/ml) and photographed 
under ultraviolet light. The AP-PCR banding patterns were visually classified according to 
previously published AP-PCR categories (Asikainen et al. 1995, Dogan et al. 1999). 
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3.3 Isolation of lipopolysaccharide (III, IV) 
LPSs of the A. actinomycetemcomitans strains were isolated by two different methods, 
sarkosyl isolation (III) and phenol-water (III, IV) extraction. In the sarkosyl extraction, the total 
bacterial cell membrane fraction was treated with Sarkosyl (sodium-lauryl sarcosinate, Sigma 
Chemical Co., St. Louis, MO, USA), in lysing buffer (0.125 M Tris-HCl, pH 6.8 containing 5% 
2-mercaptoethanol (v/v), 2% SDS (w/v), and 10% glycerol (v/v)), and digested with proteinase 
K. The phenol-chloroform extraction was done according to Al-Hendy et al. (1991). Briefly, the 
bacterial cells were suspended in TEA-buffer (40 mM Tris-acetate, pH 8.5, containing 2 mM 
EDTA), and mixed with solution containing 3% SDS (w/v), 0.6% Trizma base (w/v) (Sigma 
Chemical Co.), and 0.5% NaOH (w/v). The suspension was heated with phenol-chloroform and 
vortexed, and the supernatant was digested with proteinase K. LPS was precipitated with acetone 
and ethanol. The final precipitation was dissolved in H20.     
The LPS-concentration was determined by malonaldehyde thiobarbituric acid reaction, 
which detects the 3-deoxy-D-manno-octulsonic acid (KDO) of LPS (Waravdekar & Saslaw 
1959). The LPS activities were determined by Limulus amebocyte lysate assay with a 
chromogenic substrate (HyCult Biotechnology, Immunodiagnostic OY, Hämeenlinna, Finland). 
 
3.4 Natural transformation (II) 
The transformation assays were performed with an agar-based assay as described 
previously (Wang et al. 2002).  Briefly, recipient A. actinomycetemcomitans cells were cultured 
on trypticase soy broth (TSB) agar plates at 37°C in 5% CO2 overnight, and resuspended in TSB 
at 1 x 109 CFU/ml for the fimbriated wild-type strains or 5 x 109 for the nonfimbriated strains. 
Bacterial suspension was spotted onto a new sTSB agar plate, incubated for 2 h, and the donor 
DNA was added to the A. actinomycetemcomitans cells at a concentration of 100 µg/ ml.  The 
mixture was further incubated for 6 h, washed off the agar, and plated onto a suitable selective 
agar to enumerate the transformants.   
Both recombinant DNA and chromosomal DNA were used as donor DNA for 
transformation.  Transformation frequency was calculated as the number of transformants per 
total CFUs. Competence was defined as a transformation frequency of 10-7 or higher.  
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3.5 Isolation of serotype-specific antigen (III) 
 Isolation of the outer membrane protein (OMP) fraction. To isolate OMP 
fraction of the  A. actinomycetemcomitans serotype d (IDH 781) strain, the bacterial cells were 
broken apart by sonication on ice and the cell remnants were removed. The supernatant was 
stored at -20ºC until use. 
Isolation of the antigen.  The IgG fraction was isolated from polyclonal rabbit 
antiserum against A. actinomycetemcomitans serotype d and from the serum of an unsuccessfully 
immunized rabbit by Protein G-Sepharose 4B-column (Amersham Pharmacia Biotech, 
Piscataway, NJ, USA). The fractions containing IgG were coupled to the CNBr-activated 
Sepharose 4B matrix (Amersham Pharmacia Biotech) according to the manufacturer’s 
instructions. The supernatant containing the OMP fraction was recycled in the IgG columns. 
Unspecific binding was eliminated by recycling the supernatant in the column containing IgG 
from an unsuccessfully immunized rabbit. In order to isolate the serotype-specific antigen, the 
flow-through fraction was recycled in the column coupled by the IgG-fraction of the antiserum 
raised against serotype d. The peak fractions containing the unspecifically bound material and 
the antigenic fraction were pooled. 
 
3.6 Characterization of serotype-specific antigen (III) 
The isolated fraction containing the antigen was electrophoresed in a 12.5% SDS-
PAGE (Laemmli et al. 1979), and the gels were silver-stained (Hitchcock and Brown 1983) or 
immunoblotted with polyclonal antibodies raised against the strains of A. 
actinomycetemcomitans serotypes a through e (ATCC 29523, ATCC 43781, ATCC 33384, 
IDH781, and IDH1708, respectively) (Saarela et al. 1992).  
The specificity of the fraction was examined by a displacement-ELISA modified from the 
established ELISA method (Pussinen et al. 2002). Briefly, the formalin-fixed A. 
actinomycetemcomitans whole-cell suspension was used to coat microtiter plates (Cliniplate Uni, 
Labsystems, Helsinki, Finland). Polyclonal antisera against different A. actinomycetemcomitans 
serotypes alone or mixed with increasing amounts of isolated serotype-specific antigen or LPS 
isolated from A. actinomycetemcomitans serotype d used as a competitor were added on the 
microtiter plate. The bound antibodies were visualized using HRP-coupled goat anti-rabbit IgG 
(Sigma Chemical Co., St. Louis, MO, USA).  
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3.7 Isolation and labeling of low density lipoprotein (IV) 
LDL was isolated from human plasma after 12 h of fasting by sequential 
ultracentrifugation using solid KBr to adjust the density (Havel et al. 1955). The LDL fraction 
was washed by reflotation at its upper density, 1.063 g/ml, dialyzed against PBS, and used fresh. 
Lipoprotein-deficient plasma (LPDS) was isolated at a density >1.21 g/ml and dialyzed against 
PBS. Protein concentrations were determined by Lowry’s method (Lowry 1951). 
LDL cholesteryl ester (CE) moiety was labeled with [3H]-cholesteryl oleate (Amersham 
Biosciences, Piscataway, NJ, USA) as described earlier (Hough & Zilversmit 1984). Briefly, 
label (in toluene, Amersham Biosciences) and phosphatidylcholine (stock 100 mg/ml in 
chloroform, Sigma-Aldrich Finland, YA-Kemia, Helsinki, Finland) were dried under nitrogen 
and diluted in PBS. The solution was sonicated on ice, and LPDS and LDL were added. The 
mixture was incubated at 37°C o/n, and labeled [3H]-LDL was re-isolated by ultracentrifugation 
as described above.  
 
3.8 Low density lipoprotein uptake by macrophages (IV) 
Radioactive assays. Macrophages were cultivated in the presence of LDL and increasing 
concentrations of LPS. LDL used in the experiments was a mixture of [3H]- LDL (20%) and cold 
LDL (80%). The mixtures of LDL and LPS were added into each well, and the cells were 
cultivated in 5% CO2. After incubation with LDL and/or LPS, the cells were washed and then 
broken apart with 0.3 N NaOH. The cell suspensions were collected and their radioactivity and 
protein concentration determined (Lowry 1951).  
Lipid staining. Foam cell formation was quantified after a neutral lipid staining. 
Following incubation in the presence of LDL with or without LPS, the cells attached to cover 
slips were washed and fixed. The cells were stained with Oil Red O in isopropanol. The cover 
slips were mounted on an objective glass and examined immediately at a 40x magnification by 
phase contrast microscopy. The CE–laden macrophages were scored by counting 500 cells from 
each cover slip.  
 
3.9 Cytokine expression (IV) 
            IL-1β and TNF-α expression induced by LPS treatment was determined using 
commercial kits (R&D Systems, MN, USA and Biosource International, CA, USA). The cell 
media were collected and centrifuged, and the supernatants were stored at –70°C until used.  
 
 37
3.10 RNA isolation (IV) 
The total RNA was isolated by using an RNAeasy Mini Kit (Qiagen, Merk Eurolab Oy, 
Finland) according to the manufacturer’s instructions. The purity and concentration of the 
isolated RNA was determined at absorbances of 280 nm and 260 nm and agarose gel 
electrophoresis.  
 
3.11 Real-time PCR (IV) 
Before first-strand cDNA synthesis, contaminating genomic DNA was eliminated.  
Real-time PCR was performed with the Amplifluor Universal Amplification and 
Detection System (Intergen). The gene-specific tailed/untailed primers are listed in Table 5. The 
fluorescence signal was recorded during the annealing step. Each sample was run in triplicate. 
Real-time PCR efficiency (E) values were determined for each target gene. The relative 
expression ratio (R) of the target gene was calculated as follows: R = (Etarget)∆CTtarget (sample 1 − sample 
2) (Pfaffl 2001). In analysis of results, relative expression levels were normalized to 
porphobilinogen deaminase (PBGD) expression. Results were calculated from two independent 
experiments starting from reverse transcription.  
 
3.12 Statistics.  
            The statistical differences in the distribution of A. actinomycetemcomitans serotypes and 
genotypes between study groups as well as the natural transformation between the periodontal 
groups were determined by χ2 and Fisher’s exact tests using a StatView program.  
             The statistical significance of the differences in foam cell formation and cytokine 
production between the A. actinomycetemcomitans strains was determined by the Mann-Whitney 
U-test using SPSS program for Windows. 
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RESULTS AND DISCUSSION 
 
1. ACTINOBACILLUS ACTINOMYCETEMCOMITANS SEROTYPES IN RELATION TO 
THEIR PROPORTION IN SUBGINGIVAL FLORA (Study I) 
 
To examine the relationship between an A. actinomycetemcomitans serotype and its 
proportion of the total subgingival flora, the study material was divided into three groups 
according to the proportion of A. actinomycetemcomitans of the total flora. The groups were i) 
low (mean proportion of A. actinomycetemcomitans 0.04%, SD 0.03%, n=49), ii) intermediate 
(mean proportion 1.31%, SD 1.24, n=58), and iii) high (mean proportion 18.09%, SD 20.07, 
n=14). A. actinomycetemcomitans serotype b isolates were found statistically significantly 
(p<0.05) more frequently in the high-proportion group than in the intermediate- and low-
proportion groups. A statistically significant difference was also found in the detection frequency 
of serotype c isolates, which decreased as the proportion of A. actinomycetemcomitans of the 
total flora increased. The serotype distribution was similar to that previously reported for Finnish 
patients with periodontitis (Dogan et al. 1999). Serotype b (n=43, 35.5%) was the most common 
serotype among the present 121 A. actinomycetemcomitans strains, whereas only one isolate 
(0.8%) of serotype d was found. The dominance of serotype b among these patients with 
periodontitis is consistent with earlier studies in which serotype b has been associated with both 
juvenile and adult forms of periodontitis (Zambon et al. 1983, Asikainen et al. 1991, Yang et al. 
2004). The dominance of serotype c in the lowest-proportion groups also correlates with earlier 
findings that serotype c is related to periodontal health (Zambon et al. 1983, Asikainen et al. 
1991). We suggest that serotype b is more competent in the oral cavity than the other A. 
actinomycetemcomitans serotypes and has the ability to grow in elevated proportions in 
periodontal pockets.  
To further study the relationship between A. actinomycetemcomitans isolates and their 
respective proportions of the total subgingival flora, 60 strains were genotyped by AP-PCR. 
These 60 isolates were divided into two groups (n=28 and n=32) with a cut-off proportion of A. 
actinomycetemcomitans of 0.1%. Within serotype b strains, the AP-PCR genotypes 8 and 16 
occurred only in the high-proportion group, and the difference in their distribution was 
statistically significant (p<0.04) between the low- and high-proportion groups. Genotype 3 
occurred statistically significantly more frequently in the low-proportion group (13/28, 46%) 
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than in the high-proportion group (5/32, 15%). Among the genotype 3 isolates, four were 
nonserotypeable and all the others were of serotype c.  
The finding that serotype b was related to high proportions of A. actinomycetemcomitans is 
consistent with recent reports in the literature (Yang et al. 2005). The proportions of serotype c 
are also higher in periodontally healthy individuals than in patients with periodontitis (Yang et 
al. 2005). A. actinomycetemcomitans serotype b exhibits increased virulence potential (Brogan et 
al. 1994, Ebersole et al. 1995, Barretto Tinoco et al. 1997, Haubeck et al. 1997), and of the AP-
PCR genotypes, genotype 2, which is of serotype b, predominates in adult periodontitis 
(Asikainen et al. 1997). In the present study, genotypes 8 and 16 were associated with high 
proportions of the species in the patients with adult periodontitis. This finding suggests that at 
some point during the evolution of serotype b –clones of A. actinomycetemcomitans have 
harbored factors that give these strains an advantage for colonization and growth in the 
periodontal pocket ecology.  
.  
2. NATURAL TRANSFORMATION AMONG ACTINOBACILLUS 
ACTINOMYCETEMCOMITANS SEROTYPES (Study II) 
 
Because of our previous findings that some A. actinomycetemcomitans serotypes may 
grow in elevated proportions in subgingival flora and previous literature describing only serotype 
a strains of A. actinomycetemcomitans being naturally competent for transformation (Wang et al. 
2002), we screened A. actinomycetemcomitans strains of all known serotypes for natural 
transformation. Our hypothesis was that natural transformation is related to the serotype of A. 
actinomycetemcomitans.  
Transformable A. actinomycetemcomitans strains were found in three serotypes: a, d, and 
e.  The proportions of the transformable strains were 67% (12/18) for serotype a, 50% (3/6) for 
serotype d, and 75% (3/4) for serotype e.  None of the strains of the serotypes b, c, and f (21, 14, 
and 3 strains, respectively) were transformable.  The transformation frequencies of competent A. 
actinomycetemcomitans strains varied from 5x10-3 to 4x10-6 (median 1.5x10-4).  The distinction 
between competent and noncompetent A. actinomycetemcomitans was clear.  Seventeen of the 18 
competent A. actinomycetemcomitans strains exhibited a greater than 10-5 transformation 
frequency, which is at least 1000 times above the detection limit of the assay.   
We also investigated whether a relationship existed between the transformability of the 
strains and the periodontal status of the patients from whom A. actinomycetemcomitans strains 
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were isolated. We did not find a significant relationship between the transformability of the 
strains and aggressive or chronic periodontitis. The number of isolates from nonperiodontitis 
subjects was too low to determine whether a difference was present in the prevalence of 
competent strains between periodontitis and nonperiodontitis subjects. Our results indicated that 
competence for natural transformation of A. actinomycetemcomitans is limited to serotypes a, d, 
and e.  Competence was determined with the recombinant donor DNA pilA’-Sper-pilC’, which 
was derived from the highly conserved gene cluster pilABCD in A. actinomycetemcomitans 
(Wang et al. 2003). The results are not likely attributable to the lack of sequence homology 
between the donor DNA and the genome of the recipient A. actinomycetemcomitans.  
Transformation assays were also performed with chromosomal markers (NalrRifr), and the 
results were consistent with those performed with recombinant DNA.      
H. pylori is another heterogeneous species that is competent for natural transformation 
(Dubnau 1999). It is responsible for various gastric illnesses and is associated with certain 
malignancies, but less than 10% of affected subjects exhibit clinical symptoms (Dunn 1997). The 
genetic diversity of H. pylori has been suggested to be due to natural transformation and 
recombination (Carrol et al. 2004). A recent review speculates that some of the individuals 
harbouring H. pylori might even benefit from the organism (Carrol et al. 2004). This idea is 
interesting and might also explain the dual role of A. actinomycetemcomitans in the oral cavity; 
some clones have harboured genes more pathogenic than others via point mutations (Haubek et 
al. 1997) or natural transformation. The evolution of bacteria and mankind has occurred at the 
same time and has influenced each other (Blaser 1999, Carrol et al. 2004).  
The most significant finding of this study was the concordance of natural competence and the 
clonal lineages of A. actinomycetemcomitans.  There are several possible explanations for this 
observation.  All A. actinomycetemcomitans might be competent for transformation, but the 
conditions for induction of competence may differ, or, alternatively, genes for natural 
competence may be selectively inactivated in certain clonal lineages of A. 
actinomycetemcomitans. Certain clones of the species may also possess restriction-modification 
systems that limit the natural transformation, as suggested for H. pylori (Aras et al. 2002).  
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3. SEROTYPE-SPECIFIC ANTIGEN OF SEROTYPE D (Study III) 
 
3.1 Western blot of Actinobacillus actinomycetemcomitans lipopolysaccharide. 
Among the 120 A. actinomycetemcomitans isolates in Study I, only one isolate of 
serotype d was detected. Because of its rare existence, we hypothesized that serotype d belongs 
to the normal subgingival flora. Earlier studies on distribution of A. actinomycetemcomitans 
serotype d support this suggestion; serotype d has been detected equally from patients with and 
without periodontitis (detection frequency 0-20%) (Dogan 1999). Because of the suggested 
immunodominance of the serotype b–specific antigen (Page et al. 1991) and the O-antigen 
structure of serotype d differing from other serotypes (Nakano et al. 2000), the LPSs of five 
clinical A. actinomycetemcomitans serotype d strains and one reference strain (IDH781) were 
characterized. The LPSs of these strains were run in SDS gel electrophoresis and immunoblotted 
with polyclonal antisera raised against A. actinomycetemcomitans strains of the serotypes (a-e). 
The membrane treated with the anti-d antiserum displayed a 30- to 70-kDa ladder-like structure, 
which was not seen in the blots treated with the other antisera. This ladder-like banding pattern 
was seen only in Western blots of serotype d strains; strains of other A. actinomycetemcomitans 
serotypes had a smeared low molecular weight band with a size of 15-20 kDa. A similar ladder-
like banding pattern has been detected from serotype d -specific antigen isolated from cell lysates 
of the A. actinomycetemcomitans strain IDH781 by proteinase K treatment (Nakano et al. 2000).  
 
3.2 Characterization of affinity-purified serotype d antigen 
Because the ladder-like banding pattern of serotype d isolates was seen only when 
Western blots were treated with the polyclonal antiserum against A. actinomycetemcomitans 
serotype d, we proposed that the serotype-specific antigen of serotype d could be located in the 
O-antigen of LPS. Since there was no report in the literature describing the location of the 
serotype-specific antigen of A. actinomycetemcomitans serotype d, our aim was to isolate and 
characterize it. The fraction containing the isolated A. actinomycetemcomitans serotype d–
specific antigen and the nonspecific antigenic material isolated from the antiserum of an 
unsuccessfully immunized rabbit, which served as a negative control, were analyzed by Western 
blot. The antigens were detected with polyclonal antisera raised against the five A. 
actinomycetemcomitans serotypes (a-e). Only when treated with the antiserum against serotype d 
did the blot containing the affinity-purified serotype d fraction display a ladder-like structure 
similar to that seen in LPS isolated from IDH781. Since the pattern was not seen when the LPS 
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isolated from IDH781 and affinity-purified serotype d fraction were ran in the SDS-PAGE and 
immunoblotted with antisera raised against other A. actinomycetemcomitans serotypes (a, b, c, 
and e), we suggest that it is serotype-specific. This ladder-like banding pattern resembled that 
characteristic of LPS O-antigen. 
To further analyze the specificity of the isolated serotype d -specific antigen, we 
used displacement-ELISA. In the assay, the isolated fractions competed with the immobilized 
whole-cell antigen for binding to the corresponding antiserum. The affinity-purified serotype d 
fraction displaced binding of antiserum against IDH781 to serotype d whole cells up to 51% in a 
concentration-dependent manner (Figure 4A, of Study III). The affinity-purified serotype d 
fraction did not act as a competitor in the displacement-ELISA of other serotypes. As measured 
by malonaldehyde-thiobarbituric acid reaction, the affinity-purified serotype d fraction contained 
0.13 µg/ml of LPS. The displacement-ELISA was repeated with known LPS-concentrations. 
LPS isolated from E. coli and the LPS isolated from IDH781 were used as control competitors at 
the same concentration (0.13 µg/ml) as the affinity-purified serotype d. LPS isolated from A. 
actinomycetemcomitans serotype d displaced the binding of antiserum against A. 
actinomycetemcomitans serotype d only to serotype d whole cells up to 67%, similarly to the 
affinity-purified serotype d fraction. E. coli LPS did not significantly interfere with binding in 
any of the displacement-ELISA experiments. Displacement occurred only in competition 
situations between serotype d whole cells and the affinity-purified serotype d fraction and 
between serotype d whole cells and LPS isolated from A. actinomycetemcomitans serotype d. 
Thus, our antigen likely has the same composition as the isolated serotype d LPS.  
The location of the serotype-specific antigen in the LPS affects the virulence 
potential of LPS. LPS is a component on the surface of Gram-negative bacteria that can induce 
several systemic diseases, including septic shock (Brade et al. 1988). Moreover, one of the 
mechanisms underlying the relationship between chronic infections and CVD has been suggested 
to be mediated by LPS (Funk et al. 1993, Marcus & Hajjar 1993). The composition of the O-
antigen of LPS varies between A. actinomycetemcomitans serotypes (Perry et al. 1996a, 1996b). 
If the serotype-specific antigen is dependent on the O-antigen of the species, there may be 
serotype variation in the severity of LPS-mediated host reactions.   
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4. EFFECTS OF ACTINOBACILUS ACTINOMYCETEMCOMITANS 
LIPOPOLYSACCHARIDE ON MURINE MACROPHAGES (Study IV) 
 
The mechanism(s) by which LPS isolated from A. actinomycetemcomitans 
promotes atherogenic effects in the macrophages was investigated next. We determined whether 
the serotypes associated with elevated proportions of the species in the periodontal pocket would 
be potential inducers of proatherogenic changes in the macrophages. The role of the O-antigen of 
LPS in macrophage modulation was also studied. To this end, we investigated foam cell 
formation, inhibition of two HDL receptors, and cytokine production in the murine macrophages 
after incubation with LPS isolated from A. actinomycetemcomitans serotypes b and d. The 
murine macrophage cell line used in this study, RAW 264.7, is a widely used and well 
characterized mouse cell line that is suitable model organism for human monocytes/ 
macrophages in this kind of studies (Fitzgerald et al. 2000).  
 
4.1 Foam cell formation 
Macrophage-derived foam cell formation was detected in the presence of LDL and 
LPS isolated from JP2 and Y4, which represent A. actinomycetemcomitans serotype b, and IDH 
781, which represents A. actinomycetemcomitans serotype d. As detected with Oil Red O 
staining, after 24 hours of cultivation, (mean ±SD) 40±2.0%, 27±1.4%, and 23±1.2% of the cells 
were foam cells, respectively. The foam cell formation induced by JP2-LPS was significantly 
more effective than that of the strains Y4 and IDH 781 (p<0.01). In control cells, which were 
cultivated in the absence of LDL and LPS, no lipid accumulation was observed after 24 h. In the 
presence of LDL but without LPS, cytoplasmic lipid droplets were observed in approximately 
9±3% of the cells.  
  After the qualitative Oil Red O staining, foam cell formation was detected 
quantitatively with radioactively labeled LDL. With all LPS preparations, the LDL uptake was 
both time- and LPS concentration-dependent. At 24 h and 48 h, the uptake of CE induced by 
JP2-LPS was significantly (p=0.05) higher than that of IDH781-LPS. The effectiveness of LPS 
isolated from two strains representing A. actinomycetemcomitans serotype b (JP2 and Y4) 
differed, but did not reach statistical significance, although the ability of JP2-LPS to cause 
cholesterol accumulation was faster than that of Y4-LPS.  
The LPS of the serotype b strain JP2 was the most efficient in inducing the foam 
cell formation in the mouse macrophages, whereas the lipoprotein metabolism of macrophages 
 44
was affected least by the LPS isolated from the serotype d strain (IDH781). The structure of LPS 
differs between the A. actinomycetemcomitans serotypes. LPS of the serotype d O-antigen 
consists of repeating tetrasaccharide units, whereas serotype b O-antigen is composed of 
repeating disaccharides (Perry et al. 1996a, 1996b). As shown in Study III, serotype-specific 
antigen of serotype d contains O-antigen of LPS. To our knowledge, however, no studies have 
shown that O-antigen structure considerably affects LPS activity. It has been suggested that the 
O-antigen of LPS may influence the activity of the lipid A portion of LPS (Kondakova et al. 
2004), but the activation of macrophages is suggested to depend most on the lipid A structure 
(Muller-Loennies et al. 1998). Variations in the structure of lipid A, such as in the number of 
acyl chains, the saturation degree of fatty acids, or the conical/concave shape, may lead to 
dramatic changes in the biological activity of the compound (Schromm et al. 2000, Baranova et 
al. 2002). Based on these previous studies, the possibility remains that the differences in the 
atherogenic ability between the LPSs isolated from A. actinomycetemcomitans strains are due to 
structural variations in lipid A and not those in the O-antigen. In this case, the difference would 
not be purely serotype-dependent, which is also supported by the differences found between the 
two strains of serotype b. Alternatively, the atherogenic effects of LPS may be mediated by both 
the lipid A structure and the O-antigen.  
 
4.2 Expression of SR-BI and ABCA-1 mRNA 
To identify possible mechanisms underlying the LPS-induced cholesterol 
accumulation into the macrophages, the expression levels of two HDL receptors were 
determined. Macrophages have several surface receptors, which can mediate efflux of excess 
cholesterol. SR-BI facilitates the bidirectional efflux of free cholesterol between cells and HDL 
(Jian et al. 1998), and ABCA-1 mediates the unidirectional efflux of cellular cholesterol and 
phospholipids to lipid-poor apoA-I (Lawn et al. 1999). JP2- and E. coli -LPS significantly 
inhibited the ABCA-1 mRNA expression by 59±13% and 71±4%, respectively, compared with 
control cells with no LPS. None of the LPS preparations had a significant effect on the 
expression of SR-BI if inhibition of more than 50% was considered significant. 
The expression rate of these two transporters in concert with ABCG-1 (Wang et al. 
2004) regulates the amount of cholesterol in macrophages (Glass & Witztum 2001). In the 
present studies, of LPS preparations isolated from A. actinomycetemcomitans, only JP2-LPS 
inhibited the mRNA expression of ABCA-1 significantly. LPSs from Escherichia coli and 
Salmonella enterica have earlier been shown to downregulate the mRNA expression levels of 
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both SR-B1 and ABCA1 as well as protein levels of ABCA1 in mouse macrophages (Baranova 
et al. 2002, Khovidunkit et al. 2003). Even though differences were present in the ability of the 
two serotype b strains to inhibit the expression of ABCA1, at least some of the serotype b strains 
appear to contain LPS that is more atherogenic than LPS isolated from other serotype b strains. 
Interestingly, LPS of this particular clone of A. actinomycetemcomitans has the strongest 
potential to induce proatherogenic effects in macrophages. Further studies with larger numbers 
of strains are needed to confirm these preliminary results. 
LPS isolated from A. actinomycetemcomitans induced IL-1β and TNF-α production 
by macrophages. LPS preparations of all the strains used in the study induced the production of 
these cytokines in a time-dependent manner. LPS isolated from IDH781 produced significantly 
lower levels of TNF-α than LPS isolated from serotype b strains, whereas no differences were 
seen in the induction of IL-1β between the LPS preparations.  Serum LPS concentrations from 
patients with periodontitis have been shown to correlate with the IL-1β and TNF-α production by 
macrophages, but the bacterial origin of LPS was not investigated (Pussinen et al. 2004b). A. 
actinomycetemcomitans has been demonstrated to induce IL-1β and TNF-α production also in 
human macrophages (Sosroseno et al. 2002, Kelk et al. 2005).   
Based on these results, we conclude that A. actinomycetemcomitans LPS may 
promote proatherogenic effects by modulating macrophage function. LPS not only enhances 
foam cell formation but may also impair cholesterol efflux through reduced expression of 
ABCA-1. Among the LPS preparations isolated from different A. actinomycetemcomitans 
strains, JP2-LPS representing serotype b was the most effective inducer of foam cell formation 
and cytokine production and was the only A. actinomycetemcomitans strain suppressing the 
expression of ABCA-1 significantly. LPS isolated from serotype d strain IDH 781 did not 
suppress the expression of HDL receptors and induced foam cell formation and cytokine 
production by macrophages less than serotype b strains. Thus, the proatherogenic potential of A. 
actinomycetemcomitans LPS may depend on the infecting A. actinomycetemcomitans clones and 
correlate with the periodontopathogenic potential of the species. 
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CONCLUSIONS 
 
This study investigated the dual role of A. actinomycetemcomitans as a pathogen 
and as a part of the normal oral flora.  
A. actinomycetemcomitans serotype b strains were found to grow in elevated 
proportions in the subgingival flora of patients with periodontitis. This result supports previous 
findings in which serotype b has been associated with periodontitis. The study further suggests 
that certain A. actinomycetemcomitans clonotypes have the ability to break the health-compatible 
homeostasis in the subgingival ecosystem, leading to an overrepresentation of the clonotype. 
Natural transformation may be one of the mechanisms in the evolution of the bacteria by which 
new genetic material, e.g. virulence factors, can be imported to the genome. Natural competence 
for transformation was observed among A. actinomycetemcomitans serotypes a, d, and e, but any 
benefit derived  from this ability remains unknown and requires further investigation.   
 
 
 
A. actinomycetemcomitans          Proportion in          Proatherogenic potential 
serotype         periodontitis 
 
Serotype b High  
Low Serotype c 
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Intermediate Serotype d Low proatherogenic 
properties 
 
 
 Intermediate Serotype e 
 
 
 
 
 
 
Figure 5. Hypothesized relationship between the colonizing clone of A. actinomycetemcomitans and
proatherogenic changes in the host.  
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 Serotype d –specific antigen was found to contain the O-antigenic part of 
lipopolysaccharide. Lipopolysaccharide of A. actinomycetemcomitans was proatherogenic in 
vitro, and differences were present in proatherogenicity between A. actinomycetemcomitans 
serotypes. A. actinomycetemcomitans serotype b is the most likely inducer of proatherogenic 
effects. This is the first study to report variation in the proatherogenic properties of a pathogen. 
Interestingly, the same clonotypes of the species are the most likely inducers of both 
periodontitis and proatherogenic mechanisms (Fig. 5). The proatherogenic structure of LPS is 
unknown and warrants further study. 
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